Prestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was USD 565.61 million compared to USD 566.29 million a year ago. Revenue was USD 565.63 million compared to USD 566.33 million a year ago. Net income was USD 106.84 million compared to USD 106.3 million a year ago. Basic earnings per share from continuing operations was USD 2.15 compared to USD 2.12 a year ago. Diluted earnings per share from continuing operations was USD 2.13 compared to USD 2.11 a year ago.